메뉴 건너뛰기




Volumn 10, Issue 11 SUPPL. 18, 2005, Pages 22-25

Behavioral and neuropsychiatric outcomes in Alzheimer's disease

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; DONEPEZIL; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NOOTROPIC AGENT; PLACEBO; PSYCHOTROPIC AGENT;

EID: 28944454132     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900014206     Document Type: Review
Times cited : (27)

References (23)
  • 2
    • 0029887389 scopus 로고    scopus 로고
    • The spectrum of behavioral changes in Alzheimer's disease
    • Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology. 1996;46:130-135.
    • (1996) Neurology , vol.46 , pp. 130-135
    • Mega, M.S.1    Cummings, J.L.2    Fiorello, T.3    Gornbein, J.4
  • 4
    • 0035190585 scopus 로고    scopus 로고
    • Alzheimer's disease and other dementia in nursing homes: Levels of management and cost
    • O'Brien JA, Caro JJ. Alzheimer's disease and other dementia in nursing homes: levels of management and cost. Int Psychogeriatr. 2001;13:347-358.
    • (2001) Int Psychogeriatr , vol.13 , pp. 347-358
    • O'Brien, J.A.1    Caro, J.J.2
  • 5
    • 0036288732 scopus 로고    scopus 로고
    • Estimating the relationship between disease progression and cost of care in dementia
    • Wolstenholme J, Fenn P, Gray A, et al. Estimating the relationship between disease progression and cost of care in dementia. Br J Psychiatry. 2002;181:36-42.
    • (2002) Br J Psychiatry , vol.181 , pp. 36-42
    • Wolstenholme, J.1    Fenn, P.2    Gray, A.3
  • 6
    • 0037321045 scopus 로고    scopus 로고
    • The incremental effect of dementia-related problem behaviors on the time to nursing home placement in poor, frail, demented older people
    • Phillips VL, Diwan S. The incremental effect of dementia-related problem behaviors on the time to nursing home placement in poor, frail, demented older people. J Am Geriatr Soc. 2003;51:188-193.
    • (2003) J Am Geriatr Soc , vol.51 , pp. 188-193
    • Phillips, V.L.1    Diwan, S.2
  • 7
    • 0031925574 scopus 로고    scopus 로고
    • Psychosocial and behavioral interventions for Alzheimer's disease patients and their families
    • Beck C. Psychosocial and behavioral interventions for Alzheimer's disease patients and their families. Am J Geriatr Psychiatry. 1998;6(2 suppl 1):S41-S48.
    • (1998) Am J Geriatr Psychiatry , vol.6 , Issue.2 SUPPL. 1
    • Beck, C.1
  • 9
    • 28944453427 scopus 로고    scopus 로고
    • East Hanover, NJ: Novartis Pharmaceuticals
    • Exelon (package insert). East Hanover, NJ: Novartis Pharmaceuticals; 2004.
    • (2004) Exelon (Package Insert)
  • 10
    • 1242311898 scopus 로고    scopus 로고
    • St. Louis, MO; Forest Laboratories
    • Namenda (package insert). St. Louis, MO; Forest Laboratories; 2003.
    • (2003) Namenda (Package Insert)
  • 11
    • 28944443009 scopus 로고    scopus 로고
    • Titusville, NJ: Ortho-McNeil Neurologics
    • Razadyne (package insert). Titusville, NJ: Ortho-McNeil Neurologics; 2005.
    • (2005) Razadyne (Package Insert)
  • 12
    • 33846807625 scopus 로고    scopus 로고
    • The Expert Consensus Guideline Series: Pharmacotherapy in older patients
    • Oct special report
    • Alexopoulos GS, Katz IR, Reynolds CF, et al. The Expert Consensus Guideline Series: pharmacotherapy in older patients. Postgrad Med. 2001;110(Oct special report):1-86.
    • (2001) Postgrad Med , vol.110 , pp. 1-86
    • Alexopoulos, G.S.1    Katz, I.R.2    Reynolds, C.F.3
  • 13
    • 0035826771 scopus 로고    scopus 로고
    • Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
    • Doody RS, Stevens JC, Beck C, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1154-1166.
    • (2001) Neurology , vol.56 , pp. 1154-1166
    • Doody, R.S.1    Stevens, J.C.2    Beck, C.3
  • 14
    • 2942616386 scopus 로고    scopus 로고
    • Noncognitive symptoms and long-term treatment expectations for Alzheimer disease
    • Blesa R. Noncognitive symptoms and long-term treatment expectations for Alzheimer disease. Alzheimer Dis Assoc Disord. 2004;(18 suppl 1):S9-S16.
    • (2004) Alzheimer Dis Assoc Disord , Issue.18 SUPPL. 1
    • Blesa, R.1
  • 15
    • 0035964226 scopus 로고    scopus 로고
    • A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
    • Feldman H, Gauthier S, Hecker J, et al. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology. 2001;57:613-620.
    • (2001) Neurology , vol.57 , pp. 613-620
    • Feldman, H.1    Gauthier, S.2    Hecker, J.3
  • 16
    • 0036942425 scopus 로고    scopus 로고
    • Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease
    • Gauthier S, Feldman H, Hecker J, et al. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Int Psychogeriatr. 2002;14:389-404.
    • (2002) Int Psychogeriatr , vol.14 , pp. 389-404
    • Gauthier, S.1    Feldman, H.2    Hecker, J.3
  • 17
    • 28944432437 scopus 로고    scopus 로고
    • Functional and behavioral effects of memantine in Alzheimer's disease. Poster presented; April 24-May 1, San Francisco, CA
    • Cummings JL, van Dyck C, Schmitt FA, et al. Functional and behavioral effects of memantine in Alzheimer's disease. Poster presented at: The 56th Annual Meeting of the American Academy of Neurology; April 24-May 1, 2004; San Francisco, CA.
    • (2004) 56th Annual Meeting of the American Academy of Neurology
    • Cummings, J.L.1    Van Dyck, C.2    Schmitt, F.A.3
  • 19
    • 23244442841 scopus 로고    scopus 로고
    • Increased mortality among elderly patients with dementia using atypical antipsychotics
    • Singh S, Wooltorton E. Increased mortality among elderly patients with dementia using atypical antipsychotics. CMAJ. 2005;173:252.
    • (2005) CMAJ , vol.173 , pp. 252
    • Singh, S.1    Wooltorton, E.2
  • 20
    • 14744273100 scopus 로고    scopus 로고
    • Treatment of behavioural and psychiatric symptoms in dementia: Implications of recent safety warnings
    • Bullock R. Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings. Curr Med Res Opin. 2005;21:1-10.
    • (2005) Curr Med Res Opin , vol.21 , pp. 1-10
    • Bullock, R.1
  • 21
    • 0035728196 scopus 로고    scopus 로고
    • Iatrogenic disorders associated with conventional vs. atypical antipsychotics
    • Nasrallah HA, Mulvihill T. Iatrogenic disorders associated with conventional vs. atypical antipsychotics. Ann Clin Psychiatry. 2001;13:215-227.
    • (2001) Ann Clin Psychiatry , vol.13 , pp. 215-227
    • Nasrallah, H.A.1    Mulvihill, T.2
  • 22
    • 4043100585 scopus 로고    scopus 로고
    • Behavioral and psychological symptoms in dementia: The role of atypical antipsychotics
    • Lawlor BA. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics. J Clin Psychiatry. 2004;65(suppl 11):5-10.
    • (2004) J Clin Psychiatry , vol.65 , Issue.SUPPL. 11 , pp. 5-10
    • Lawlor, B.A.1
  • 23
    • 0035009765 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitors for late-life depression: A comparative review
    • Solai LK, Mulsant BH, Pollock BG. Selective serotonin reuptake inhibitors for late-life depression: a comparative review. Drugs Aging. 2001;18:355-368.
    • (2001) Drugs Aging , vol.18 , pp. 355-368
    • Solai, L.K.1    Mulsant, B.H.2    Pollock, B.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.